Drug Stores Market Research Reports & Industry Analysis
The majority of drug store sales are due to the number of prescriptions they fill, as prescriptions are the initial cause of customer traffic in the store. The remaining profit they generate comes from the sale of the “front-end” items. The volume of “front-end” merchandise in drug stores is growing due to drug store companies expanding the selection in order to increase revenue.
The demand for drug stores is dependent upon the need for medical prescriptions, the aging population, and new advances and innovations in medical care. Competition exists between different companies involved in manufacturing of the goods found in drug stores, and also between alternative retailers that offer similar services. Large drug store companies have advantages in purchasing for their locations, and as they are already established in the market they have access to an extensive consumer base. Smaller drug store companies strive to achieve effective and creative advertising strategies to garner more consumer traffic, and also focus on operating out of convenient locations. Independent companies primarily rely on their accessibility to medical insurance businesses to generate a profit.
Drug Stores Industry Research & Market Reports
-
Middle East And Africa Beauty And Personal Care Market 2022-2028
... to witness growth, with a CAGR of 3.52% in the forecast duration from 2022 to 2028. South Africa, Saudi Arabia, Israel, the United Arab Emirates, and Rest of Middle East & Africa are studied in ... Read More
-
Latin America Beauty And Personal Care Market 2022-2028
... and 2028, according to Triton Market Research’s report. Brazil, Mexico, and Rest of Latin America are scrutinized in the market in this region. Peru is an important market in Rest of Latin America. The Peruvian ... Read More
-
LATAM Fabry Disease Market, by Therapy Type (Enzyme Replacement Therapy (Agalsidase Beta (Fabrazyme), Agalsidase Alfa (Replagal), Pegunigalsidase Alfa (PRX-102, Phase III)) Chaperon Therapy (Migalastat (Galafold Phase III)), Substrate Reduction Therapy (Lucerastat (Phase III), Venglustat (Phase III))), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospitals Pharmacies, Online pharmacies, Retail Pharmacies), and by Country (Brazil, Argentina, Mexico, Rest of Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... III))), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospitals Pharmacies, Online pharmacies, Retail Pharmacies), and by Country (Brazil, Argentina, Mexico, Rest of Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - ... Read More
-
Pharmacy & Drug Store Franchises in the US - Industry Market Research Report
... positive upstream trends that are driving demand for pharmacies and drug stores nationwide. These trends include the effects of healthcare reform, which has increased the number of Americans with private health insurance. Additionally, the number ... Read More
-
Veterinary Pain Management Market by Product (Drug (NSAIDs, Opioids), Route of Administration (Oral, Parenteral), Device (Laser)), Application (Joint Pain, Cancer), Animal (Companion and Livestock), End User (Hospital, Pharmacy) - Global Forecast to 2027
... pain management market is projected to reach USD 2.5 Billion by 2027 from USD 1.8 Billion in 2022, at a CAGR of 6.7% during the forecast period. This market is subsegmented into by Product, Application, ... Read More
-
Over the Counter Drugs Market, By Product Type (Cough, Cold, and Flu Products, Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Mineral, and Supplements (VMS), Weight-loss/Dietary Products, Ophthalmic Products, Sleeping Aids, and Other Product Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, and Other Distribution Channels), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, and Other Distribution Channels), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Over-the-counter ... Read More
-
Asia Pacific Branded Generics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Therapeutic Application (Oncology, Cardiovascular Diseases, Diabetes, Neurology, Gastrointestinal Diseases, Dermatology Diseases, Analgesics and Anti-Inflammatory, and Others), Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies, and Drug Stores), Drug Class (Alkylating Agents, Antimetabolites, Hormones, Antihypertensive, Lipid-Lowering Drugs, Antidepressants, Antipsychotics, Antiepileptic, and Others), and Formulation Type (Oral, Parenteral, Topical, and Others)
... Retail Pharmacies, Online Pharmacies, and Drug Stores), Drug Class (Alkylating Agents, Antimetabolites, Hormones, Antihypertensive, Lipid-Lowering Drugs, Antidepressants, Antipsychotics, Antiepileptic, and Others), and Formulation Type (Oral, Parenteral, Topical, and Others) The branded generics market in Asia ... Read More
-
Europe Branded Generics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Therapeutic Application (Oncology, Cardiovascular Diseases, Diabetes, Neurology, Gastrointestinal Diseases, Dermatology Diseases, Analgesics and Anti-Inflammatory, and Others), Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies, and Drug Stores), Drug Class (Alkylating Agents, Antimetabolites, Hormones, Antihypertensive, Lipid-Lowering Drugs, Antidepressants, Antipsychotics, Antiepileptic, and Others), and Formulation Type (Oral, Parenteral, Topical, and Others)
... Pharmacies, Online Pharmacies, and Drug Stores), Drug Class (Alkylating Agents, Antimetabolites, Hormones, Antihypertensive, Lipid-Lowering Drugs, Antidepressants, Antipsychotics, Antiepileptic, and Others), and Formulation Type (Oral, Parenteral, Topical, and Others) The branded generics market in Europe is ... Read More
-
Middle East & Africa Branded Generics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Therapeutic Application (Oncology, Cardiovascular Diseases, Diabetes, Neurology, Gastrointestinal Diseases, Dermatology Diseases, Analgesics & Anti-Inflammatory, and Others), Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies, and Drug Stores), Drug Class (Alkylating Agents, Antimetabolites, Hormones, Antihypertensive, Lipid-Lowering Drugs, Antidepressants, Antipsychotics, Antiepileptic, and Others), and Formulation Type (Oral, Parenteral, Topical, and Others)
... Channel (Hospitals, Retail Pharmacies, Online Pharmacies, and Drug Stores), Drug Class (Alkylating Agents, Antimetabolites, Hormones, Antihypertensive, Lipid-Lowering Drugs, Antidepressants, Antipsychotics, Antiepileptic, and Others), and Formulation Type (Oral, Parenteral, Topical, and Others) The branded generics market ... Read More
-
South & Central America Branded Generics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Therapeutic Application (Oncology, Cardiovascular Diseases, Diabetes, Neurology, Gastrointestinal Diseases, Dermatology Diseases, Analgesics and Anti-Inflammatory, and Others), Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies, and Drug Stores), Drug Class (Alkylating Agents, Antimetabolites, Hormones, Antihypertensive, Lipid-Lowering Drugs, Antidepressants, Antipsychotics, Antiepileptic, and Others), and Formulation Type (Oral, Parenteral, Topical, and Others)
... Channel (Hospitals, Retail Pharmacies, Online Pharmacies, and Drug Stores), Drug Class (Alkylating Agents, Antimetabolites, Hormones, Antihypertensive, Lipid-Lowering Drugs, Antidepressants, Antipsychotics, Antiepileptic, and Others), and Formulation Type (Oral, Parenteral, Topical, and Others) The branded generics market ... Read More
-
Compounding Pharmacies Market, by Product Type (Oral (Capsule, Tablets, Mixtures, Lollipops, Lozenges), Topical (Gels, Ointments, Cream, Lotions), Rectal, Parenteral, Nasal, Ophthalmic and Mouthwashes) , by Therapeutic Area (Pain Management, Hormone Replacement Therapy (HRT),Dermatology and Specialty Drugs), by Application (Pediatric, Adults, Geriatrics and Veterinary), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Drugs), by Application (Pediatric, Adults, Geriatrics and Veterinary), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Compounded medications are prepared ... Read More
-
Acute Bacterial Skin and Skin Structure Infections (ABSSSI ) Market, by Drug Type (Oral & Parenteral Antibiotics (Oritavancin, Delafloxacin, Vancomycin, Daptomycin, Dalbavancin, Ceftaroline, Linezolid, Tedizolid, Clindamycin, and Others (Rifampin, Doxycycline, Minocycline, Trimethoprim-Sulfa Methoxazol, etc.)) and Topical Antibiotics (Hydrogen Peroxide, Fusidic Acid, Mupirocin, Retapamulin, and Povidone-Iodine)), by Infection Type (Hospital Acquired ABSSSI and Community Acquired ABSSSI), by Route of Administration (Oral, Parenteral, and Topical), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Topical Antibiotics (Hydrogen Peroxide, Fusidic Acid, Mupirocin, Retapamulin, and Povidone-Iodine)), by Infection Type (Hospital Acquired ABSSSI and Community Acquired ABSSSI), by Route of Administration (Oral, Parenteral, and Topical), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, ... Read More
-
Drug Stores and Pharmacies (Pharmacy), plus Nutrition, Beauty and Health Products Stores Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2028, NAIC 446000
... rates and forecasts that will save countless hours of research. Key Findings: Drug Stores and Pharmacies (Pharmacy), plus Nutrition, Beauty and Health Products Stores Industry (U.S.) to reach $388,929,313,250 million by 2029. Drug Stores and ... Read More
-
Pharmacies and Drug Stores Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2028, NAIC 446110
... of research. Key Findings: Pharmacies and Drug Stores Industry (U.S.) to reach $333,908,294,300 million by 2029. Pharmacies and Drug Stores Industry, including Average EBITDA, Operating Ratios and Sales per Employee. Core Benefits to Customer: 1) ... Read More
-
Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2028, NAIC 424200
... countless hours of research. Key Findings: Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors Industry (U.S.) to reach $916,620,445,623 million by 2029. Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors Industry, including Average EBITDA, Operating Ratios and Sales per ... Read More
-
Pharmaceuticals and Druggists' Merchandise Distributors Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2028, NAIC 424210
... hours of research. Key Findings: Pharmaceuticals and Druggists' Merchandise Distributors Industry (U.S.) to reach $916,620,445,623 million by 2029. Pharmaceuticals and Druggists' Merchandise Distributors Industry, including Average EBITDA, Operating Ratios and Sales per Employee. Core Benefits ... Read More
-
Sexual Wellness Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Pharmaceutical Product (Capsules, Tablets, Oral Liquids, and Sprays), Non-Pharmaceutical Product (Sex Toys, Condoms, Intrauterine Devices, Contraceptive Implants, and Others), and Distribution Channel (Retail Pharmacies, Online Distribution, Mass Merchandize, and Hospitals Pharmacies) Application (Erectile Dysfunction (ED) Treatment, Premature Ejaculation Treatment, Low Libido Improvement, Orgasmic Dysfunction Treatment, and Others)
... (Retail Pharmacies, Online Distribution, Mass Merchandize, and Hospitals Pharmacies) Application (Erectile Dysfunction (ED) Treatment, Premature Ejaculation Treatment, Low Libido Improvement, Orgasmic Dysfunction Treatment, and Others) The sexual wellness market is projected to reach US$ 81,394.49 ... Read More
-
Dietary Supplements Market, by Form (Soft gel/Pills (Confectionery Products (Gummies, Chews, Others (Lollipops, hard-boiled candies)), Pharmaceutical Products (Chewable Pills and Pills, Gelcaps)), Powder, Liquid), by Application (Weight Loss, Sports Nutrition, General Wellbeing, Immune and Digestive Health, Bone and Joint Health, Heart Health, Other Specific Requirements (Beauty Supplements, Anti-Allergies, and Eye Health)), by Ingredients (Vitamins & Minerals, Amino Acids, Botanical Supplements, Others (Concentrate, Metabolite, Constituent, and Extract)), by End-use (Men, Women, Senior Citizens, Others (Kids and Toddlers)), by Distribution Channel (Pharmacies & Drugstores, Health & Beauty Stores, Hypermarkets & Supermarkets, Online, Direct Selling), and by Region (North America, Latin America, Europe, Asia-pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Health, Bone and Joint Health, Heart Health, Other Specific Requirements (Beauty Supplements, Anti-Allergies, and Eye Health)), by Ingredients (Vitamins & Minerals, Amino Acids, Botanical Supplements, Others (Concentrate, Metabolite, Constituent, and Extract)), by End-use (Men, Women, ... Read More
-
Pharmacies and Healthcare Stores Global Market Briefing 2022: Ukraine-Russia War Impact
... accounting for 4.6%. In terms of per capita consumption, the market was $141.1 and in terms of global GDP, the market was 1.13%. Pharmacies and healthcare stores was the eighth largest segment within the retail ... Read More
-
Cosmetics And Personal Care Stores Global Market Briefing 2022: Ukraine-Russia War Impact
... accounting for 1.1%. In terms of per capita consumption, the market was $36.3 and in terms of global GDP, the market was 0.29%. Cosmetics and personal care stores was the fifteenth largest segment within the ... Read More
-
Sjogren’s Syndrome Market, by Drug (Antimalarial Quinolines, Cholinergic Agonists, Corticosteroids and Others (Pain Relief Medication and late phase drug)), by type (Primary and Secondary), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Sjogren’s syndrome is systematic autoimmune disorder which effect the entire body, along ... Read More
-
Global Tinnitus Drug Market Size study, by Treatment Type (Anti-Depressants, Anti- Anxiety, Anti-histamines, Anti-convulsant), Distribution Channel (Retail Pharmacies, Drug stores, E-commerce), and Regional Forecasts 2022-2028
... million in 2021 and is anticipated to grow with a healthy growth rate of more than 7.50% over the forecast period 2022-2028. Tinnitus is defined as a condition in which a person intentionally hears noises ... Read More
-
Global Allergic Conjunctivitis Market Size study, By Drug Class (Antihistamines & Mast Cell Stabilizers, Corticosteroids), By Disease Type (Seasonal Allergic Conjunctivitis (SAC), Perennial Allergic Conjunctivitis (PAC)), By Distribution Channel (Hospital Pharmacies, Drug stores & Retail Pharmacies, Online providers), and Regional Forecasts 2022-2028
... Pharmacies, Online providers), and Regional Forecasts 2022-2028 Global Allergic Conjunctivitis Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over ... Read More
-
Monkeypox Treatment Market, by Treatment Type (Prophylactic (vaccines), Therapeutics (Tecovirimat, Brincidofovir, Cidofovir)), by Route of Administration (Oral, Injectable), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Middle East, Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 A rare condition known as monkeypox is brought on by infection with the monkeypox virus. The smallpox virus and ... Read More
-
Smoking Cessation and Nicotine De-Addiction Products Market By Product (Nicotine Replacement Therapy Products, Drug Therapy, E-cigarettes), By Form (Gum, Inhaler, Tablet, Others), By Distribution Channel (Hospital Pharmacies, Online Provider, Drug stores and Retail Pharmacies): Global Opportunity Analysis and Industry Forecast, 2021-2031
... Opportunity Analysis and Industry Forecast, 2021-2031 The global smoking cessation and nicotine de-addiction products market was valued at $19,965.28million in 2021, and is estimated to reach $54,708.87 million by 2031, growing at a CAGR of ... Read More
Research Assistance
